###begin article-title 0
###xml 68 72 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 84 88 <span type="species:ncbi:10090">Mice</span>
The Flavonoid Luteolin Worsens Chemical-Induced Colitis in NF-kappaBEGFP Transgenic Mice through Blockade of NF-kappaB-Dependent Protective Molecules
###end article-title 0
###begin p 1
Conceived and designed the experiments: CJ TK. Performed the experiments: TK JK BJ. Analyzed the data: CJ TK. Wrote the paper: CJ TK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The flavonoid luteolin has anti-inflammatory properties both in vivo and in vitro. However, the impact of luteolin on experimental models of colitis is unknown.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 56 60 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 304 307 300 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 317 321 309 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 410 414 398 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 585 588 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 598 602 582 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 874 877 854 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1148 1152 1124 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 61 76 <span type="species:ncbi:10090">transgenic mice</span>
###xml 322 337 <span type="species:ncbi:10090">transgenic mice</span>
###xml 415 430 <span type="species:ncbi:10090">transgenic mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
###xml 1153 1168 <span type="species:ncbi:10090">transgenic mice</span>
To address the therapeutic impact of luteolin, NF-kappaBEGFP transgenic mice were fed a chow diet containing 2% luteolin- or isoflavone-free control chow (AIN-76), and acute colitis was induced using 3% dextran sodium sulfate (DSS). Additionally, development of spontaneous colitis was evaluated in IL-10-/-;NF-kappaBEGFP transgenic mice fed 2% luteolin chow diet or control chow diet. Interestingly, NF-kappaBEGFP transgenic mice exposed to luteolin showed worse DSS-induced colitis (weight loss, histological scores) compared to control-fed mice, whereas spontaneous colitis in IL-10-/-;NF-kappaBEGFP mice was significantly attenuated. Macroscopic imaging of live resected colon showed enhanced EGFP expression (NF-kappaB activity) in luteolin-fed mice as compared to control-fed animals after DSS exposure, while cecal EGFP expression was attenuated in luteolin-fed IL-10-/- mice. Interestingly, confocal microscopy showed that EGFP positive cells were mostly located in the lamina propria and not in the epithelium. Caspase 3 activation was significantly enhanced whereas COX-2 gene expression was reduced in luteolin-fed, DSS-exposed NF-kappaBEGFP transgenic mice as assessed by Western blot and immunohistochemical analysis. In vitro, luteolin sensitized colonic epithelial HT29 cells to TNFalpha-induced apoptosis, caspase 3 activation, DNA fragmentation and reduced TNFalpha-induced C-IAP1, C-IAP2 and COX-2 gene expression.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
We conclude that while luteolin shows beneficial effects on spontaneous colitis, it aggravates DSS-induced experimental colitis by blocking NF-kappaB-dependent protective molecules in enterocytes.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 337 340 337 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Ley1">[1]</xref>
###xml 342 345 342 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Haller1">[2]</xref>
###xml 728 731 728 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Loftus1">[3]</xref>
###xml 863 866 863 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Hanauer1">[4]</xref>
###xml 1075 1078 1075 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Bouma1">[5]</xref>
###xml 1218 1221 1218 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Sartor1">[6]</xref>
###xml 1389 1392 1381 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Cominelli1">[7]</xref>
###xml 1602 1605 1590 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Karrasch1">[8]</xref>
###xml 1704 1707 1692 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Neurath1">[9]</xref>
###xml 1709 1713 1697 1701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Jobin1">[10]</xref>
The gastrointestinal tract of higher organisms is lined by a single layer of intestinal epithelial cells. This physical barrier separates subepithelial mucosal immune cells such as lymphocytes and myeloid cells from a variety of antigenic substances present within the intestinal lumen (e.g. bacteria, bacterial products, food antigens) [1], [2]. Consequently, the integrity of the epithelial barrier is essential for the maintenance of host homeostasis, as it prevents a dysregulated uptake of luminal antigens. The incidence and prevalence of ulcerative colitis and Crohn's disease, collectively referred to as inflammatory bowel diseases (IBD), have been increasing in developed countries worldwide over the last few decades [3]. Of note, the knowledge of basic molecular and cellular mechanisms leading to IBD has significantly increased over the past decade [4]. For example, multiple studies support the concept that an improper activation of effector T cells in conjunction with insufficient regulatory T cell activity are key events leading to the development of IBD [5]. Interestingly, the endogenous intestinal flora itself seems to play an important role in initiating the dysregulated host immune response [6], leading to the release of a number of inflammatory mediators such as IL-1, IL-6, IL-12, IL-23, TNFalpha and IFNgamma that participate in the pathology of the disease [7]. The transcription factor NF-kappaB controls the production of many of these inflammatory mediators, and we recently demonstrated its important role in driving bacteria-induced chronic intestinal inflammation [8]. Consequently, this transcriptional system represents a potential therapeutic target to treat IBD [9], [10].
###end p 9
###begin p 10
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Hibi1">[11]</xref>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Bent1">[12]</xref>
###xml 740 744 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Gupta1">[13]</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Sampson1">[14]</xref>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
Mainstream treatments to manage IBD are largely based on immunosuppressive approaches with broad acting agents such as prednisone, cyclosporin A and tacrolimus (FK506) [11]. Although these are relatively effective, a number of patients develop significant side effects and/or become unresponsive to them. These concerns and the perception that alternative medicine is "healthier" than classical therapeutic options lead a growing segment of the population to seek alternative treatments to ameliorate various disorders including chronic intestinal inflammation [12]. This is clearly exemplified by the considerable amount of money spent by the general population on alternative medicine with an estimated world market of 62 billion dollars [13], [14]. Herbal medicine encompassing extracts or active components derived from plants, barks, roots, leaves, flowers, and fruits represents an extremely popular segment of alternative medicine. However, despite their clear popularity, absence of empirical data showing efficacy and mechanisms of action in vivo prevents their incorporation into mainstream medicine.
###end p 10
###begin p 11
###xml 120 124 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Aggarwal1">[15]</xref>
###xml 339 343 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Ross1">[16]</xref>
###xml 345 349 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Manach1">[17]</xref>
###xml 508 512 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Kim1">[18]</xref>
###xml 634 638 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Hendriks1">[19]</xref>
###xml 639 643 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Ruiz1">[24]</xref>
###xml 231 238 <span type="species:ncbi:4039">carrots</span>
Of interest, a large number of dietary products have been shown to inhibit NF-kappaB activity in different cell systems [15]. Luteolin for example is a flavonoid present in significant amounts in vegetables including celery, sage, carrots and broccoli, and a healthy diet is believed to contain between 2 mg and 125 mg of luteolin per day [16], [17]. We recently demonstrated that luteolin suppresses LPS-induced NF-kappaB signaling both in vivo and in vitro through inhibition of the IkappaB-kinase complex [18]. In addition, numerous other studies have shown the anti-inflammatory action of this flavonoid both in vivo and in vitro [19]-[24]. Consequently, this polyphenolic compound may have a beneficial impact either in treating IBD or preventing their development.
###end p 11
###begin p 12
###xml 184 188 176 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 198 201 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 211 215 199 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 662 665 646 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 675 679 655 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 216 231 <span type="species:ncbi:10090">transgenic mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
In the present study, we examined the impact of luteolin on the DSS model of acute colitis in mice. To follow patterns of NF-kappaB activation, we conducted experiments using NF-kappaBEGFP and IL-10-/-;NF-kappaBEGFP transgenic mice, which express the reporter gene enhanced green fluorescent protein (EGFP) under control of the NF-kappaB promoter. We found that luteolin significantly enhanced intestinal epithelial cell caspase-3 activation and prevented the induction of cytoprotective molecules such as COX-2 following DSS-exposure. DSS-exposed, luteolin-fed mice demonstrated more severe colitis than control-fed animals, whereas spontaneous colitis in IL-10-/-;NF-kappaBEGFP mice was significantly attenuated. We conclude that while luteolin shows beneficial effects on spontaneous colitis, it aggravates DSS-induced experimental colitis by blocking NF-kappaB-dependent protective molecules in enterocytes.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
DSS-induced acute colitis
###end title 14
###begin p 15
###xml 13 17 9 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 60 64 56 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Magness1">[25]</xref>
###xml 655 659 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Sugimoto1">[26]</xref>
###xml 661 665 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Jian1">[27]</xref>
###xml 18 33 <span type="species:ncbi:10090">transgenic mice</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">Mice</span>
###xml 521 525 <span type="species:ncbi:10090">Mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 1071 1076 <span type="species:ncbi:10090">mouse</span>
###xml 1136 1140 <span type="species:ncbi:10090">Mice</span>
###xml 1296 1300 <span type="species:ncbi:10090">mice</span>
The NF-kappaBEGFP transgenic mice were described previously [25]. These mice allow the real-time assessment of NF-kappaB activity (EGFP expression) during various experimental treatments. Mice were maintained in standard housing cages in a specific pathogen free (SPF) environment and allowed to drink and feed ad libitum at all times. Luteolin (SYNORx; San Clemente, CA) was incorporated in standard laboratory chow AIN-76 in different amounts (weight-percentages: 0.5%, 2%, 5%) (Research Diets Inc; New Brunswick, NJ). Mice (7/group) were pre-fed luteolin-chow (0.5%, 2%, 5%) or control chow (AIN-76) for 3 days (loading period) as described previously [26], [27]. After this time, mice were given 3% DSS (MP Biomedicals; Aurora, OH) in drinking water for an additional 6 days. Control mice were given water. Water consumption was comparable between the different groups. Similarly, chow consumption (control AIN76 and luteolin) was comparable between DSS and water control groups, both before and during the induction of colitis (daily consumption approximately 1.6 g/mouse, equaling 32 mg luteolin; differences</=0.08 g/day or 5%). Mice were monitored daily for weight loss as well as signs of rectal bleeding (Hemoccult, Beckmann Coulter Inc; Fullerton, CA). At day 6 of DSS administration, mice were sacrificed, sections were taken from the distal colon for histological assessment of inflammation and EGFP-expression was imaged as described below.
###end p 15
###begin title 16
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 41 45 37 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 46 61 <span type="species:ncbi:10090">transgenic mice</span>
Spontaneous colitis in IL-10-/-;NF-kappaBEGFP transgenic mice
###end title 16
###begin p 17
###xml 5 10 5 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 76 80 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 117 122 113 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 132 136 124 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 146 149 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 159 163 147 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 254 259 242 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 269 273 253 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 283 286 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 296 300 276 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
IL-10wt/wt and IL-10-/- mice (Sv129 background) were cross-bred to NF-kappaBEGFP mice (C57Bl/6 background), and IL-10wt/wt;NF-kappaBEGFP and IL-10-/-;NF-kappaBEGFP mice generated in the F2-generation were derived into germ-free condition. Germ-free IL-10wt/wt;NF-kappaBEGFP and IL-10-/-;NF-kappaBEGFP littermates were transferred to a specific-pathogen-free (SPF) environment and immediately placed on a diet containing 2%-luteolin versus AIN-76-control-chow (7/group). After 4 weeks, mice were sacrificed, sections were taken from cecum and distal colon for histological assessment of inflammation and EGFP-expression was imaged as described below. All animal experiments were approved by the Institutional Animal Care and Use Committee of the University of North Carolina at Chapel Hill.
###end p 17
###begin title 18
Sample collection and histological evaluation
###end title 18
###begin p 19
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Okayasu1">[28]</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Cooper1">[29]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Williams1">[30]</xref>
###xml 748 752 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Cooper1">[29]</xref>
###xml 766 770 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Dieleman1">[31]</xref>
###xml 797 801 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Williams1">[30]</xref>
###xml 945 948 941 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1284 1288 1280 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Sellon1">[32]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 949 953 <span type="species:ncbi:10090">mice</span>
Mice were sacrificed at designated time-points by CO2 asphyxiation. The entire colon was dissected and flushed with ice-cold PBS. Colonic cross-sections were taken, fixed in 10% formalin for 24 h and embedded in paraffin to provide sections for histological evaluation. Severity of colitis was evaluated in Hematoxylin-Eosin-stained sections by an experienced investigator blinded to the experimental conditions. For DSS-induced colitis, the distal colon was evaluated because it has been demonstrated to be the most severely affected colonic segment in DSS-induced colitis [28], [29] and to provide a score representing the disease severity in the entire colon [30]. Coded sections were scored using a validated scoring system developed by Cooper [29] and Dieleman [31], and modified by Williams [30] using a scale of 0 to 40. For each animal, 2 sections approximately 400 microm apart were scored and averaged. For spontaneous colitis in IL-10-/- mice, mucosal inflammation was evaluated in cross-sections of the cecum and the distal colon separately. Sections were scored in a blinded fashion on a scale from 0 to 4, based on the degree of lamina propria mononuclear cell infiltration, crypt hyperplasia, goblet cell depletion and architectural distortion, as previously described [32].
###end p 19
###begin title 20
Immunohistochemical evaluation
###end title 20
###begin p 21
Colonic sections were prepared as described above. Immunohistochemical staining for activated caspase 3 (antibodies to cleaved caspase-3 (Asp175); Cell Signaling Technology Inc; Beverly, MA) and cyclooxygenase 2 (COX-2) (Cayman Chemical; Ann Arbor, MI) was performed according to the manufacturer's directions. The sections were counterstained with a mixture of methyl-green and alcian-blue. Two different sections (per animal) approximately 400 microm apart were evaluated, and representative sections are shown.
###end p 21
###begin title 22
Primary intestinal epithelial cell isolation
###end title 22
###begin p 23
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Jijon1">[33]</xref>
Primary intestinal epithelial cells were isolated as described previously [33]. Briefly, colons were opened longitudinally, and colonic intestinal epithelial cells were separated by shaking the colons in a solution containing 3 mM EDTA and 0.5 mM DTT for 90 min. The remaining tissue was discarded and epithelial cells in the supernatant were spun down at 1000 rpm for 5 min. The cell pellet was then directly lysed in 1x Laemmli buffer. Vimentin or CD64, markers for myofibroblasts and myeloid cells respectively, were not detected, whereas the epithelial marker cytokeratin was strongly expressed in our epithelial cell preparation as assayed by Western blot analysis (data not shown).
###end p 23
###begin title 24
HT29 cell culture, stimulation, cell and whole colonic tissue protein isolation
###end title 24
###begin p 25
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Haller2">[34]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human transformed colonic epithelial HT29 cells (passage 20-30) (American Type Culture Collection (ATCC); Manassas, VA) were cultured as described previously [34]. Before experiments, cells were starved overnight in serum-reduced media (1% serum). Where indicated, HT29 cells were treated with luteolin (SYNORx; San Clemente, CA) dissolved in DMSO, TNFalpha (R&D Systems; Minneapolis, MN) or solvent control for designated times, respectively. DMSO alone had no biological effect on the various in vitro readouts (data not shown). Stimulated or control treated HT29 cells were collected and directly lysed in 1X Laemmli buffer.
###end p 25
###begin p 26
###xml 16 20 <span type="species:ncbi:10090">mice</span>
The colons from mice in the various groups were dissected, flushed with ice-cold PBS and homogenized for 15 s with a polytron (IKA Works Inc; Wilmington, NC) in a solution containing 50 mM Hepes, 150 mM NaCl, 20 mM NaPyrophosphate, 100 mM NaF, 1% Triton X-100, 10 mM EDTA and 1X Proteinase inhibitors (Complete Mini, Roche Diagnostics GmbH; Penzberg, Germany). After incubation at 4degreesC for 30 min with gentle agitation, undissolved contents were spun down and the supernatant mixed 1:1 with 2x Laemmli buffer.
###end p 26
###begin title 27
Western Blot analysis
###end title 27
###begin p 28
###xml 667 671 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Jobin2">[35]</xref>
The protein concentration of lysates was measured using Bio-Rad quantification assay (Bio-Rad Laboratories; Hercules, CA). Proteins (20 microg) were separated using 10% (13% for caspase analysis) SDS-PAGE and transferred to nitrocellulose membranes. Antibodies to COX-2 (Cayman Chemicals; Ann Arbor, MI), cleaved caspases 3, 8 and 9 (Cell Signaling Technology Inc, Beverly, MA) and beta-actin (ICN; Costa Mesa, CA) were used at a dilution of 1:1000 in a solution containing 5% milk in TBS-Tween (0.1%). Immunoreactive proteins were detected using the enhanced chemiluminescence light (ECL) detecting kit (Amersham Biosciences, Piscataway, NJ) as described previously [35].
###end p 28
###begin title 29
Macroscopic and confocal assessment of EGFP expression
###end title 29
###begin p 30
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were sacrificed at designated time points, the entire colon dissected and then directly imaged for EGFP expression in a light-tight imaging box without further preparation using a CCD camera and emission filters specific for EGFP (Lightools Research; Encinitas, CA).
###end p 30
###begin p 31
For confocal microscopy, the colons were opened longitudinally and placed on the stage of a Leica SP2 Upright Laser Scanning Confocal Microscope (Leica, Germany), lumen side facing the objective lens without further processing or fixation. EGFP was excited with a 495 nm laser, and images were acquired using detection filters specific for the EGFP emission spectrum. Images were overlayed with those obtained using transmitted light, allowing for spacial orientation relative to the shadows of the crypts. Images were analyzed using the Leica SP2 Laser Scanning Confocal Software (Leica, Germany).
###end p 31
###begin title 32
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
PGE2 secretion
###end title 32
###begin p 33
###xml 78 79 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Luteolin-treated cells were stimulated with TNFalpha (5 ng/ml) for 24 h. A PGE2 enzyme linked immunosorbent assay (ELISA) of cell culture supernatants was performed in triplicate according to the manufacturer's instructions (Assay Designs; Ann Arbor, MI).
###end p 33
###begin title 34
RNA extraction and amplification by RT-PCR
###end title 34
###begin p 35
###xml 143 147 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Jobin2">[35]</xref>
###xml 770 774 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Cui1">[36]</xref>
###xml 175 180 <span type="species:ncbi:10090">mouse</span>
###xml 524 529 <span type="species:ncbi:9606">human</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
###xml 733 738 <span type="species:ncbi:9606">human</span>
###xml 849 854 <span type="species:ncbi:9606">human</span>
###xml 953 958 <span type="species:ncbi:9606">human</span>
RNA was isolated using the TRIzol method (Invitrogen; Carlsbad, CA), reverse transcribed (1 microg RNA), and amplified as previously described [35] using specific primers for mouse C-IAP1, C-IAP2, X-IAP, COX-2 and beta-actin. The PCR products were separated on 2% agarose gels containing gel Star fluorescent dye (FMC; Philadelphia, PA). Fluorescence staining was captured using an Alpha Imager 2000 (AlphaInnotech; San Leandro, CA). Sequences of primers were 5'-CAATTCGGCACCATAACTCTG-3' and 5'-CCTGTGGTTAAATCTGCCTTG-3' for human C-IAP1 (amplicon length 1067 pb), 5'-CAAGTAGATGAGGGTAACTGGC-3' and 5'-AAGTTCCATCCCCTGTCCAATG-3' for human C-IAP2 (amplicon length 550 pb), 5'-CTTGCATACTGTCTTTCTGAGC-3' and 5'-ACACCATATACCCGAGGAAC-3' for human X-IAP (amplicon length 818 pb) [36], 5'-AGATCATCTCTGCCTGAGTATCTT-3' and 5'-TTCAAATGAGATTGTGGGAAAATTGCT-3' for human COX-2 (amplicon length 304 pb) and 5'-CCAACCGCGAGAAGATGACC-3' and 5'-GATCTTCATGAGGTAGTCAGT-3' for human beta-actin (amplicon length 235 pb).
###end p 35
###begin title 36
DNA fragmentation analysis and apoptosis detection
###end title 36
###begin p 37
HT29 cells were grown in six well plates and at 80% of confluence were treated with various amounts of luteolin and then stimulated with TNFalpha (20 ng/ml) for 6, 12 and 24 hours. Cells were washed twice with PBS and DNA was extracted with a hypotonic lysis buffer (10 mM Tris, 1 mM EDTA and 0,2% Triton X-100, ph 7.5). Proteinase K digestion was carried out for 16 h at 37degreesC. DNA was then extracted with phenol-chlorophorm-isoamyl-alcohol (25:24:1). After ethanol precipitation and resuspension in 10 mM Tris, 1mM EDTA, ph 8.0, the DNA was electrophoresed on a 1.5% agarose gel. A 100 bp DNA ladder (Life Technologies, Rockville, MD) was used as a molecular weight standard. DNA fragmentation was quantified by detecting histone-associated DNA fragments in enzyme linked immunoabsorbance assay (ELISA) (Boehringer Mannheim; Indianapolis, IN) according to the manufacturer's instructions.
###end p 37
###begin title 38
Caspase Activity and Inhibition
###end title 38
###begin p 39
Cells were pretreated with luteolin and then stimulated with TNFalpha as indicated above. Cells were harvested, washed twice with PBS and then lysed in Apopain Lysis Buffer (10 mM HEPES, ph 7.4, 2 mM EDTA, 0.1% CHAPS, 5 mM DTT, 1mM PMSF, 10 microg/ml pepstatin A, 10 microg/ml aprotinin, 20 microg/ml leupeptin). Lysates were cleared by centrifugation for 30 min at 12000 rpm in a microfuge at 4degreesC. Protein content was measured using the Bio-Rad protein quantification assay (Bio-Rad; Hercules, CA). Caspase-3 activity was monitored in vitro using the fluorogenic peptide substrate Z-DEVD-AFC (Bio-Rad; Hercules, CA). Fluorescence changes derived from free AFC released by caspase-3 activity were detected at 500-550 nm with a GeminiX Spectrafluorometer (Molecular Devices; Sunnyvale, CA). Results are presented in fold changes.
###end p 39
###begin title 40
Luciferase adenoviral vector infection and luciferase activity assay
###end title 40
###begin p 41
###xml 146 150 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Haller2">[34]</xref>
HT29 cells were infected for 16 h with an adenoviral vector encoding a NF-kappaB-luciferase reporter gene (Ad5kappaB-LUC) as described previously [34]. The Ad5GFP containing GFP was used as a viral vector infection negative control. The cells were washed, and fresh medium containing serum was added. Cells were then pretreated with various concentrations of luteolin or solvent control for 45 min, after which time they were stimulated with TNFalpha (5 ng/ml) for 12 h. Cell extracts were prepared using luciferase cell lysis buffer (PharMingen; San Diego, CA) according to the manufacturer's instructions. Luciferase activity was quantified using luciferase substrate solutions A and B from PharMingen and read on a Lmax luminometer microplate reader (Moleculer Devices; Sunnyvale, CA) and results were normalized to protein concentration measured with the Bio-Rad protein quantification assay (Bio-Rad; Hercules, CA).
###end p 41
###begin title 42
Intestinal epithelial cell restitution studies in vitro
###end title 42
###begin p 43
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Karrasch2">[37]</xref>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Egan1">[39]</xref>
###xml 28 31 <span type="species:ncbi:10116">rat</span>
Restitution was assessed in rat non-transformed ileal epithelial cells IEC-18 as previously described [37]-[39]. Briefly, IEC-18 cells were grown to confluency in 100 mm cell culture dishes, starved in serum-reduced media (1%) overnight and standard linear wounds were created using a sterile razor-blade. Cells were then washed once with PBS, and serum-reduced media was replenished. Restitution was calculated as migration over the wound-edge over 24 hours.
###end p 43
###begin title 44
Statistical analysis
###end title 44
###begin p 45
###xml 484 485 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Data are expressed as means+/-S.D. Groups of data (histological scores, body weight) were analyzed using Kruskal-Wallis non-parametric test and if the result indicated statistical differences (p<0.05) among groups, comparisons between groups were conducted using Mann-Whitney U test. Differences were considered significant if p<0.05. In vitro experiments were conducted in triplicates; representative results are shown. For in vitro experiments, data were analyzed by non-parametric t-test or Wilcoxon rank sum test where appropriate. Differences were considered significant if 2-tailed p values were <0.05.
###end p 45
###begin title 46
Results
###end title 46
###begin title 47
Luteolin-treatment worsens DSS-induced experimental colitis
###end title 47
###begin p 48
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Kim1">[18]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Xagorari1">[21]</xref>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Hougee1">[23]</xref>
###xml 305 309 301 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 508 512 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Magness1">[25]</xref>
###xml 523 527 511 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 819 823 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Williams1">[30]</xref>
###xml 825 829 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Dieleman1">[31]</xref>
###xml 913 917 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Kim1">[18]</xref>
###xml 1050 1057 1038 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g001">Fig. 1A</xref>
###xml 1202 1209 1190 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g001">Fig. 1B</xref>
###xml 229 235 <span type="species:ncbi:10090">murine</span>
###xml 321 326 <span type="species:ncbi:10090">mouse</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">Mice</span>
###xml 979 983 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
###xml 1244 1248 <span type="species:ncbi:10090">mice</span>
###xml 1337 1341 <span type="species:ncbi:10090">Mice</span>
###xml 1533 1537 <span type="species:ncbi:10090">mice</span>
Although the anti-inflammatory potential of the flavonoid luteolin has been established in vitro [18], [21]-[23], its therapeutic impact on different inflammatory disorders is still unclear. We tested the effect of luteolin in a murine model of chemical-induced acute intestinal inflammation. An NF-kappaBEGFP transgenic mouse recently generated by our group allows the assessment of the kinetics and cellular localization of NF-kappaB-induced transcription (EGFP expression) during an inflammatory response [25]. NF-kappaBEGFP mice (C57Bl/6; 7/group) were fed an isoflavone-free (AIN-76) or 2% luteolin diet for 3 days before being exposed to 3% DSS in drinking water ad libitum or tap water control. Mice were then sacrificed at day 6 and inflammation evaluated using established clinical and histological parameters [30], [31]. Surprisingly, although luteolin has systemic anti-inflammatory properties in vivo [18], luteolin-fed animals lost more weight than control diet-fed mice (8.8% versus 2.3% at day 4, 15.4% versus 10.2% at day 6, p<0.05) (Fig. 1A). Moreover, histological evaluation demonstrated significantly worse colitis in mice fed the luteolin chow compared to the AIN-76 control chow (Fig. 1B). Colitis was also exacerbated in mice fed a 0.5% or a 5% luteolin rich diet compared to AIN-76 control diet (data not shown). Mice fed with luteolin chow alone and exposed to water did not develop any signs of colitis (data not shown). These findings demonstrate that the flavonoid luteolin worsens DSS-induced colitis in mice.
###end p 48
###begin title 49
###xml 35 39 31 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Luteolin-fed, DSS exposed NF-kappaBEGFP mice display strong EGFP expression in the intestine
###end title 49
###begin p 50
###xml 225 229 217 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 394 401 386 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g002">Fig. 2A</xref>
###xml 657 677 649 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g002">Fig. 2A; right panel</xref>
###xml 936 943 928 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g002">Fig. 2A</xref>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 834 838 <span type="species:ncbi:10090">mice</span>
To gain insight into the molecular mechanisms involved in the worsening of colitis in luteolin-fed mice, we investigated the in vivo pattern of NF-kappaB activity. The colons of 2% luteolin or AIN-76 fed DSS-treated NF-kappaBEGFP mice were dissected and imaged using a CCD camera in a light-tight imaging box with a dual filtered light source and emission filters specific for EGFP. As seen in Fig. 2A, EGFP expression is strongly enhanced throughout the colon of DSS-exposed animals compared to water-control mice (left panel). Of note, there was no difference in the macroscopic EGFP expression in duodenal and proximal jejunal sections of the same mice (Fig. 2A; right panel). This suggests that enhanced colonic EGFP expression correlates with DSS-induced colonic damage. Interestingly, colonic EGFP expression was not blocked in mice fed the 2%-luteolin diet, but rather showed enhanced expression, especially in the distal colon (Fig. 2A).
###end p 50
###begin p 51
###xml 175 180 171 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP </sup>
###xml 223 230 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g002">Fig. 2B</xref>
###xml 498 505 494 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g002">Fig. 2B</xref>
###xml 541 548 537 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g002">Fig. 2C</xref>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
To examine the expression of EGFP at the cellular level, we visualized the distribution of the EGFP-positive cells present in colonic segments freshly harvested from NF-kappaBEGFP mice using confocal microscopy. As seen in Fig. 2B, EGFP expression was increased in colons from mice fed the 2%-luteolin diet compared to those from untreated, DSS-exposed mice. Higher magnification images demonstrated that the increased EGFP expression was confined to interstitial mononuclear cells between crypts (Fig. 2B; schematic representation shown in Fig. 2C). These findings indicate that luteolin enhances DSS-induced colitis, which correlates with increased NF-kappaB activation (EGFP expression) from colonic mucosa lamina propria mononuclear cells (LPMNC).
###end p 51
###begin title 52
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Decreased COX-2 gene expression and enhanced caspase 3 activation in luteolin fed mice following DSS exposure
###end title 52
###begin p 53
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Morteau1">[40]</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Fukata1">[41]</xref>
###xml 308 312 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Kim1">[18]</xref>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
DSS-induced colitis is exacerbated in COX-2 gene deficient mice [40], and a recent report demonstrated the importance of enterocyte-derived COX-2 gene expression for the amelioration of DSS-induced epithelial damage [41]. Since we previously showed that luteolin prevents NF-kappaB activation in enterocytes [18], we next investigated whether intestinal epithelial COX-2 expression is down-regulated in luteolin-fed mice.
###end p 53
###begin p 54
###xml 171 178 171 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g001">Fig. 1A</xref>
###xml 550 563 550 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g003">Fig. 3A, left</xref>
###xml 684 698 684 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g003">Fig. 3A, right</xref>
###xml 839 857 839 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g003">Fig. 3B; top panel</xref>
###xml 931 952 931 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g003">Fig. 3B; bottom panel</xref>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
Molecular alterations likely precede clinical signs of colitis and histopathological evidence of inflammation that generally occur after 3-4 days of DSS exposure in mice (Fig. 1A and data not shown). Therefore, we examined COX-2 expression by Western blot in enterocytes isolated from AIN-76-chow or 2%-luteolin-chow fed mice exposed to 3% DSS for only 2 days. Interestingly, COX-2 protein levels were higher in enterocytes isolated from DSS-exposed mice compared to those isolated from controls, and this effect was abrogated by luteolin treatment (Fig. 3A, left). A similar though less pronounced effect on COX-2 gene expression could be observed in total colonic protein extracts (Fig. 3A, right). Immunohistochemistry also demonstrated a strong decrease of DSS-induced COX-2 expression in enterocytes in mice fed the 2%-luteolin-chow (Fig. 3B; top panel). Isotype antibody control demonstrated the specificity of the staining (Fig. 3B; bottom panel). These results suggest that luteolin interferes with DSS-induced enterocyte-derived COX-2 gene expression.
###end p 54
###begin p 55
###xml 120 124 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Maeda1">[42]</xref>
###xml 126 130 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Tsurutani1">[43]</xref>
###xml 385 398 381 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g003">Fig. 3A, left</xref>
###xml 602 606 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Yan1">[44]</xref>
###xml 814 828 810 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g003">Fig. 3A, right</xref>
###xml 1009 1030 1005 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g003">Fig. 3B; middle panel</xref>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
NF-kappaB signaling controls numerous cellular events including cell survival through induction of anti-apoptotic genes [42], [43]. We next investigated whether luteolin would inhibit anti-apoptotic signaling in enterocytes, a process that would enhance intestinal epithelial damage by DSS. Interestingly, a small increase in caspase 3 processing was observed in isolated enterocytes (Fig. 3A, left), although baseline processing is strongly increased in these cells compared to total colonic lysates. This is likely due to cell detachment-induced apoptosis (anoikis) caused by the isolation procedure [44]. Importantly, total colonic protein obtained from luteolin-fed DSS-treated mice displayed a significant increase in caspase 3 processing compared to AIN-76-fed and DSS-treated or water control treated mice (Fig. 3A, right). Furthermore, enhanced caspase 3 processing is detected in enterocytes from luteolin-fed, DSS-exposed mice compared to control diet as determined by immunohistochemical analysis (Fig. 3B; middle panel). These results suggest that luteolin increases enterocyte caspase 3 activation after DSS-exposure.
###end p 55
###begin title 56
###xml 93 96 93 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 107 111 103 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Luteolin-treatment ameliorates spontaneous Th1-dependent colitis and EGFP expression in IL-10-/-; NF-kappaBEGFP mice
###end title 56
###begin p 57
###xml 173 178 169 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 188 192 180 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 202 205 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 215 219 203 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 582 585 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 729 732 717 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 825 832 813 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g004">Fig. 4A</xref>
###xml 907 910 895 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 920 924 904 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 931 938 915 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g004">Fig. 4A</xref>
###xml 1051 1054 1035 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1064 1068 1044 1048 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 1075 1082 1055 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g004">Fig. 4B</xref>
###xml 1194 1203 1174 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g004">Fig. 4A,B</xref>
###xml 1281 1284 1261 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 925 929 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
###xml 1188 1192 <span type="species:ncbi:10090">mice</span>
###xml 1285 1289 <span type="species:ncbi:10090">mice</span>
We next asked if the NF-kappaB-inhibiting properties of luteolin might be beneficial in a spontaneous model of chronic, Th1-mediated intestinal inflammation. Germ-free IL-10wt/wt;NF-kappaBEGFP and IL-10-/-;NF-kappaBEGFP mice were transferred to a specific-pathogen-free (SPF) environment and immediately placed on a diet containing 2% luteolin versus AIN-76 control-chow (7/group). After 4 weeks, mice were sacrificed, sections were taken from cecum and distal colon for histological assessment of inflammation and EGFP expression was imaged as described above. Interestingly, IL-10-/- mice fed with the control diet showed thickening of the colon and absence of solid stool compared to wild-type mice, whereas luteolin-fed IL-10-/- mice displayed a macroscopically healthy colon with abundant and well-formed stool pellets (Fig. 4A). Furthermore, luteolin-treatment decreased cecal EGFP expression in IL-10-/-;NF-kappaBEGFP mice (Fig. 4A). Histological assessment of inflammation showed that luteolin treatment ameliorated cecal inflammation in IL-10-/-;NF-kappaBEGFP mice (Fig. 4B). Distal colonic inflammation and EGFP expression were comparable between luteolin and AIN76 control-fed mice (Fig. 4A,B). Thus, these results do not demonstrate adverse effects of luteolin in IL-10-/- mice, but rather suggest a potential beneficial impact of this flavonoid in a model of spontaneous chronic T cell-mediated colitis.
###end p 57
###begin title 58
###xml 30 35 <span type="species:ncbi:9606">human</span>
Luteolin-treatment sensitizes human colonic intestinal epithelial cells HT29 to TNFalpha-induced apoptosis
###end title 58
###begin p 59
###xml 459 466 427 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g005">Fig. 5A</xref>
###xml 945 952 893 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g005">Fig. 5B</xref>
###xml 146 151 <span type="species:ncbi:9606">human</span>
We next characterized the impact of luteolin on TNFalpha-induced NF-kappaB activity, COX-2 and anti-apoptotic gene expression in vitro, using the human colon epithelial cell line HT29. Cells were infected for 16 h with an adenoviral vector encoding an NF-kappaB-luciferase reporter gene (Ad5kappaB-LUC), pretreated with various doses of luteolin (25 microM, 50 microM or 100 microM) for 45min and then stimulated with TNFalpha (5 ng/ml) for 12 h. As shown in Fig. 5A, luteolin (100 microM) inhibited TNFalpha-induced NF-kappaB transcriptional activity in HT29 cells. NF-kappaB-dependent anti-apoptotic genes include the cellular inhibitors of apoptosis protein-1 and -2 (C-IAP1 and C-IAP2), which selectively block the key pro-apoptotic enzymes caspase-3, -8 and -9. Interestingly, luteolin treatment completely suppressed TNFalpha-induced C-IAP1 and C-IAP2 mRNA accumulation, whereas X-IAP mRNA levels remained unchanged as measured by RT-PCR (Fig. 5B). Thus, luteolin prevents TNFalpha-induced NF-kappaB activity and anti-apoptotic gene induction.
###end p 59
###begin p 60
###xml 282 289 266 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g006">Fig. 6A</xref>
###xml 645 652 617 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g006">Fig. 6B</xref>
We next asked whether luteolin functionally impacts on HT29 cell apoptosis in the presence of TNFalpha. Cells were pretreated with luteolin (50 microM or 100 microM) for 45 min, and then exposed to TNFalpha (20 ng/ml) for 24 h, after which time genomic DNA was isolated. As seen in Fig. 6A, luteolin-treatment (100 microM) led to TNFalpha-induced DNA fragmentation in HT29 cells. Quantitative assessment of DNA fragmentation by ELISA assay for cytoplasmic oligonucleosome-bound DNA demonstrated a 2.2fold induction of DNA fragmentation in luteolin-pretreated TNFalpha stimulated cells by 12 h, which increased to 8.1fold by 24 h post-treatment (Fig. 6B). Thus, luteolin treatment leads to TNFalpha-induced DNA fragmentation in HT29 cells in vitro.
###end p 60
###begin p 61
###xml 70 79 70 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g003">Fig. 3A,B</xref>
###xml 367 374 355 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g007">Fig. 7A</xref>
###xml 584 591 564 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g007">Fig. 7B</xref>
###xml 728 735 708 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g006">Fig. 6B</xref>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Caspase-3 processing is enhanced in luteolin-fed mice exposed to DSS (Fig. 3A,B). We next investigated the impact of this flavonoid on caspase activity in the presence of TNFalpha. HT29 cells were treated with luteolin (100 microM) for 45 min, then treated with TNFalpha (20 ng/ml) for 24 h and caspase processing was determined by Western blot analysis. As shown in Fig. 7A, luteolin strongly induced caspase-3, -8 and -9 processing in the presence of TNFalpha. Moreover, luteolin induced caspase-3 activity in the presence of TNFalpha as demonstrated by a fluorescence-based assay (Fig. 7B; 2.5 fold after 12 h treatment, 7.5 fold after 24 h treatment). The kinetics of caspase activation parallel those of DNA fragmentation (Fig. 6B). In summary, luteolin blocks TNFalpha-induced NF-kappaB transcriptional activity and anti-apoptotic gene expression, but induces caspase-3, -8 and -9 processing in HT29 cells in the presence of TNFalpha in vitro.
###end p 61
###begin title 62
Luteolin-treatment suppresses TNFalpha-induced COX-2 gene expression
###end title 62
###begin p 63
###xml 114 118 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Morteau1">[40]</xref>
###xml 120 124 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Fukata1">[41]</xref>
###xml 226 230 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Karrasch2">[37]</xref>
###xml 560 566 544 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g008">Fig. 8</xref>
###xml 638 645 618 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g008">Fig. 8A</xref>
###xml 671 678 651 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g008">Fig. 8B</xref>
###xml 726 727 702 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 781 788 757 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g008">Fig. 8C</xref>
The NF-kappaB-dependent COX-2 gene has been associated with a protective host response during DSS-induced colitis [40], [41]. In addition, COX-2 gene expression has been shown to promote intestinal epithelial cell restitution [37]. We next assessed the impact of luteolin on TNFalpha-induced COX-2 gene expression in HT29 cells. Cells were treated with luteolin (100 microM) for 45 min, then treated with TNFalpha (5 ng/ml) for 12 h and 24 h and COX-2 mRNA and protein accumulation were determined by RT-PCR and Western blot analysis, respectively. As seen in Fig. 8, luteolin completely blocked TNFalpha-induced COX-2 mRNA accumulation (Fig. 8A) and protein expression (Fig. 8B) in HT29 cells. Similarly, TNFalpha-induced PGE2 secretion is blocked in luteolin-treated HT29 cells (Fig. 8C).
###end p 63
###begin title 64
Discussion
###end title 64
###begin p 65
###xml 343 347 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Egan2">[45]</xref>
###xml 349 353 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Chen2">[46]</xref>
###xml 404 407 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 485 489 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Araki1">[47]</xref>
###xml 509 510 498 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 755 759 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Brown1">[48]</xref>
###xml 1069 1070 1050 1051 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1297 1298 1278 1279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1726 1730 1707 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Oshima1">[49]</xref>
###xml 1731 1735 1712 1716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Wendum1">[51]</xref>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
###xml 1171 1174 <span type="species:ncbi:10116">rat</span>
NF-kappaB drives the expression of a subset of target genes that have important functions in salvaging enterocytes from apoptosis and in promoting restitution in various models of gastrointestinal damage. For example, ischemia-reperfusion and radiation-induced intestinal injury is worse in mice with selective IKKbeta deletion in enterocytes [45], [46]. Also, DSS-induced colitis is exacerbated in MyD88-/- mice, a critical adaptor protein involved in TLR-induced NF-kappaB signaling [47]. Interestingly, PGE2-expressing stromal cells within the lamina propria reposition near the intestinal epithelial stem cell compartment following DSS-induced injury through a MyD88-dependent mechanism, a process promoting cellular proliferation and mucosal healing [48]. Noteworthy, we found that luteolin inhibits DSS-induced, NF-kappaB dependent enterocyte COX-2 expression in both total colonic protein extracts and purified enterocytes obtained from luteolin-fed mice. Similarly, in vitro experiments showed that luteolin blocks TNFalpha-induced COX-2 gene expression and PGE2 secretion in HT29 cells. Interestingly, luteolin attenuated restitution in a wound-healing assay in rat intestinal epithelial cells IEC-18 in vitro (69% of control, p<0.01), which was partially restored by adding exogenous PGE2 (87% of control, p<0.01 versus luteolin treatment alone). Thus, COX-2 and its derivative metabolites seem to play an important role in maintaining mucosal homeostasis. Of note, it should be stressed that although blocking COX-2 expression appears detrimental in the DSS model of acute colitis, a luteolin-rich diet may be beneficial in preventing colorectal cancer, where COX-2 overexpression is associated with carcinogenesis [49]-[51].
###end p 65
###begin p 66
###xml 1640 1649 1612 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g009">Fig. 9A,C</xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 1634 1638 <span type="species:ncbi:10090">mice</span>
Exacerbated colitis in luteolin-treated, DSS-exposed mice may involve a higher susceptibility of enterocytes to undergo signal-induced apoptosis and a decreased ability to initiate restitution. This possibility is supported by our findings that luteolin fed mice displayed enhanced caspase 3 processing in colonic tissue following DSS exposure, suggesting a higher rate of apoptosis. In addition, in vitro experiments showed that luteolin sensitizes HT29 cells to TNFalpha-induced caspase-3 processing/activity as well as DNA fragmentation. These effects were associated with blockade of TNFalpha-induced NF-kappaB transcriptional activity and the concomitant decreased expression of down-stream target genes C-IAP1 and C-IAP2. The failure to maintain an intact intestinal epithelium and to repair DSS-induced intestinal epithelial damage would result in an increased uptake of luminal antigens, including bacteria and bacterial products, and thus lead to the activation of underlying immune cells and the mounting of an inflammatory response: In the DSS model of acute chemical-induced colitis, luteolin's foremost impact is likely geared towards enterocytes, inhibiting NF-kappaB-dependent protective molecules. Enhanced injury then leads to enhanced NF-kappaB activation (EGFP expression) in mononuclear cells from the colonic lamina propria, where luteolin's inhibitory effect on NF-kappaB in LPMNC is likely overcome by the strong impact of abundantly translocated luminal antigens. Enhanced lamina propria NF-kappaB activation (EGFP expression) in turn correlates with clinical and histological signs of colitis in luteolin-fed mice (Fig. 9A,C).
###end p 66
###begin p 67
###xml 167 171 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Lorenz1">[52]</xref>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
Numerous pro-inflammatory mediators are known to be associated with the development of DSS-induced acute inflammation including IL-6, IL-12, IL-17, IL-18 and TNFalpha [52]. Whether TNFalpha promotes intestinal injury and apoptosis in luteolin-fed DSS-treated mice remains to be formally shown. Similarly, the exact signaling events associated with enhanced COX-2 expression, NF-kappaB activity and caspase-3 processing in DSS-exposed mice are as of yet unclear.
###end p 67
###begin p 68
###xml 181 184 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 545 554 541 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g009">Fig. 9B,C</xref>
###xml 692 695 684 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 701 704 693 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000596-Karrasch1">[8]</xref>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
###xml 958 966 <span type="species:ncbi:9606">patients</span>
Importantly, luteolin's negative impact on acute gastrointestinal damage by DSS does not impair its potential therapeutic benefits in other experimental models, for example in IL-10-/- mice. In this spontaneous model of chronic, Th1-mediated intestinal inflammation, without primary epithelial damage, luteolin's inhibition of NF-kappaB activation (EGFP expression) is predominantly seen in lamina propria mononuclear cells (LPMNC). Its actions at least in part ameliorate the clinical and histological signs of colitis in luteolin-fed animals (Fig. 9B,C). These findings parallel our recent report demonstrating a beneficial impact of pharmacological NF-kappaB inhibition on colitis in IL-10-/- mice [8]. Our results warrant further studies of luteolin's effects in colonic dysplasia and cancer development as well as in chronic intestinal inflammation. Since herbal compounds and their derivatives are widely available and taken by an increasing number of patients oftentimes without proper medical monitoring, our study stresses the need for further analysis of their impact on various diseases.
###end p 68
###begin p 69
###xml 147 152 147 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 162 166 158 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 176 179 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 189 193 181 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 1052 1053 1044 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 911 919 <span type="species:ncbi:39367">Rosemary</span>
The authors wish to thank Kathy Mohr (Technical Director, MMRRC) for embryo dissection and transplantation during the derivation of germ-free IL-10wt/wt;NF-kappaBEGFP and IL-10-/-;NF-kappaBEGFP mice. We thank Maureen Bower and Silmara Camargo at the Gnotobiotic Core Facility of the Center for Gastrointestinal Biology and Disease for their expert help in germ-free rodent technology. We thank Wendy Salmon and Dr. Michael Chua in the Michael Hooker Microscopy Facility at the University of North Carolina at Chapel Hill for their expert advice on confocal microscopic imaging and for providing access to the Leica SP2 Upright Laser Scanning Confocal Microscope (Leica, Germany). We thank Monica Mattmuller at the College of Veterinary Medicine, North Carolina State University, Raleigh, NC, for her expert help with the immunohistochemical studies. The authors thank Kathy Thompson from the Histology Core and Rosemary Link from the Immunoassay Core of the Center for Gastroenterology Biology and Disease for expert assistance in H&E histology and PGE2 quantification, respectively. We thank Dr. Joseph A. Galanko in the Center for Gastrointestinal Biology and Disease at the University of North Carolina at Chapel Hill for his expert help on statistical analyses. The authors wish to thank Dr. Jonathan Hansen for his critical review of the manuscript. The current address of Joo-Sung Kim is Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea. The current address of Byung Ik Jang is Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
###xml 70 75 <span type="species:ncbi:9606">human</span>
Ecological and evolutionary forces shaping microbial diversity in the human intestine.
###end article-title 71
###begin article-title 72
Interaction between resident luminal bacteria and the host: can a healthy relationship turn sour?
###end article-title 72
###begin article-title 73
Epidemiology of inflammatory bowel disease.
###end article-title 73
###begin article-title 74
Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.
###end article-title 74
###begin article-title 75
The immunological and genetic basis of inflammatory bowel disease.
###end article-title 75
###begin article-title 76
Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
###end article-title 76
###begin article-title 77
Cytokine-based therapies for Crohn's disease-new paradigms.
###end article-title 77
###begin article-title 78
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Gnotobiotic IL-10-/-;NF-kappaBEGFP mice reveal the critical role of TLR/NF-kappaB signaling in commensal bacteria-induced colitis.
###end article-title 78
###begin article-title 79
###xml 147 151 <span type="species:ncbi:10090">mice</span>
Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice.
###end article-title 79
###begin article-title 80
NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases.
###end article-title 80
###begin article-title 81
Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
###end article-title 81
###begin article-title 82
Commonly used herbal medicines in the United States: a review.
###end article-title 82
###begin article-title 83
Surge in US patents on botanicals.
###end article-title 83
###begin article-title 84
Studying herbal remedies.
###end article-title 84
###begin article-title 85
Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning.
###end article-title 85
###begin article-title 86
Dietary flavonoids: bioavailability, metabolic effects, and safety.
###end article-title 86
###begin article-title 87
Polyphenols: food sources and bioavailability.
###end article-title 87
###begin article-title 88
The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells.
###end article-title 88
###begin article-title 89
Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis.
###end article-title 89
###begin article-title 90
###xml 27 47 <span type="species:ncbi:83558">Chlamydia pneumoniae</span>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model.
###end article-title 90
###begin article-title 91
Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages.
###end article-title 91
###begin article-title 92
Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships.
###end article-title 92
###begin article-title 93
Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages.
###end article-title 93
###begin article-title 94
###xml 122 128 <span type="species:ncbi:10090">murine</span>
Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells.
###end article-title 94
###begin article-title 95
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse.
###end article-title 95
###begin article-title 96
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
###end article-title 96
###begin article-title 97
###xml 70 74 <span type="species:ncbi:10116">rats</span>
Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid.
###end article-title 97
###begin article-title 98
###xml 97 101 <span type="species:ncbi:10090">mice</span>
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.
###end article-title 98
###begin article-title 99
###xml 63 69 <span type="species:ncbi:10090">murine</span>
Clinicopathologic study of dextran sulfate sodium experimental murine colitis.
###end article-title 99
###begin article-title 100
###xml 85 100 <span type="species:ncbi:10090">transgenic mice</span>
Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone.
###end article-title 100
###begin article-title 101
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.
###end article-title 101
###begin article-title 102
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.
###end article-title 102
###begin article-title 103
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 85 91 <span type="species:ncbi:10090">murine</span>
Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells.
###end article-title 103
###begin article-title 104
IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines.
###end article-title 104
###begin article-title 105
###xml 66 71 <span type="species:ncbi:9606">human</span>
Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells.
###end article-title 105
###begin article-title 106
###xml 90 95 <span type="species:ncbi:9606">human</span>
Lipopolysaccharide induces the expression of cellular inhibitor of apoptosis protein-2 in human macrophages.
###end article-title 106
###begin article-title 107
Wound-induced p38MAPK-dependent histone H3 phosphorylation correlates with increased COX-2 expression in enterocytes.
###end article-title 107
###begin article-title 108
###xml 67 70 <span type="species:ncbi:10116">rat</span>
Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers.
###end article-title 108
###begin article-title 109
Nuclear factor-kappa B activation promotes restitution of wounded intestinal epithelial monolayers.
###end article-title 109
###begin article-title 110
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.
###end article-title 110
###begin article-title 111
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.
###end article-title 111
###begin article-title 112
###xml 71 90 <span type="species:ncbi:210">Helicobacter pylori</span>
Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori.
###end article-title 112
###begin article-title 113
###xml 0 7 <span type="species:ncbi:4097">Tobacco</span>
Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells.
###end article-title 113
###begin article-title 114
Activation of NF-kappaB following detachment delays apoptosis in intestinal epithelial cells.
###end article-title 114
###begin article-title 115
IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium.
###end article-title 115
###begin article-title 116
The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.
###end article-title 116
###begin article-title 117
###xml 16 20 <span type="species:ncbi:10090">mice</span>
MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
###end article-title 117
###begin article-title 118
Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury.
###end article-title 118
###begin article-title 119
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
###end article-title 119
###begin article-title 120
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
###end article-title 120
###begin article-title 121
Cyclooxygenase-2 and its role in colorectal cancer development.
###end article-title 121
###begin article-title 122
Animal models of intestinal inflammation: ineffective communication between coalition members.
###end article-title 122
###begin title 123
Figures and Tables
###end title 123
###begin title 124
2% luteolin diet worsens DSS-induced experimental colitis as measured by weight loss and histologic score.
###end title 124
###begin p 125
###xml 158 165 158 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 373 380 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
2% luteolin or AIN-76 fed mice (n = 7 per group) were exposed to 3% DSS in drinking water ad libitum for the indicated time and monitored as described in the Methods section. Weight loss in response to DSS is presented as percent of the starting weight (* p<0.05 versus control, # p<0.05 versus DSS alone) (A). Colonic histological sections were scored as described in the Methods section (* p<0.05 versus control, # p<0.05 versus DSS alone) (B).
###end p 125
###begin title 126
###xml 63 67 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Enhanced EGFP expression in luteolin fed, DSS exposed NF-kappaBEGFP mice as compared to control diet is confined to lamina propria mononuclear cells.
###end title 126
###begin p 127
###xml 9 13 5 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 443 447 435 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 566 573 558 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
NF-kappaBEGFP mice (n = 7 per group) were sacrificed after 6 days of 3% DSS exposure, and dissected colon (left panel) and duodenum/proximal jejunum (right panel) were imaged at this time for EGFP using the Lightools Research macroimaging system with a dual output lighting (right). Photomicrographs (Nikon cool-pix digital camera) are shown on the left. Representative images are shown (A). Confocal imaging of colonic sections from NF-kappaBEGFP mice (n = 3 per group) after 6 days of 3% DSS exposure was performed immediately after dissection as described in the Methods. Representative results are shown (B). A schematic representation of the colon indicates the plane depicted in the confocal microscopic images. Importantly, EGFP accumulation (NF-kappaB activation) is predominantly seen in lamina propria mononuclear cells located in between the crypts (LPMNC, light purple and green), and not in surface and crypt epithelium, which is damaged by DSS (light grey) (C).
###end p 127
###begin title 128
2% luteolin enhances caspase 3 activation and suppresses COX-2 protein accumulation in enterocytes after DSS exposure.
###end title 128
###begin p 129
###xml 9 13 5 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 448 452 436 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
NF-kappaBEGFP mice (n = 7/group) were sacrificed after 2 days of 3% DSS exposure and protein (20 microg) from primary enterocytes (A, left) and total colonic lysates (A, right) were subjected to SDS-PAGE. COX-2 expression and caspase 3 processing were evaluated using specific antibodies against cleaved caspase 3 and COX-2, respectively, and immunoreactive proteins were detected using the enhanced chemiluminescence (ECL) technique (A). NF-kappaBEGFP mice (n = 7/group) were sacrificed after 2 days of 3% DSS exposure, and cellular localization of COX-2 proteins (top panel) and caspase 3 processing (middle panel) were analyzed in the colon using IHC. Sections were counterstained with a mixture of methyl-green and alcian-blue. An isotype-control antibody was used to determine staining specificity on the same colonic section (lower panel). Representative results out of 2 different sections per each animal (n = 14/group) are shown (B).
###end p 129
###begin title 130
###xml 111 114 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 124 128 120 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
2% luteolin diet ameliorates cecal colitis and decreases lamina-propria EGFP expression in SPF-associated IL-10-/-;NF-kappaBEGFP mice.
###end title 130
###begin p 131
###xml 15 20 15 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 30 34 26 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 44 47 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 57 61 49 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 362 370 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000596-g002">figure 2</xref>
###xml 439 444 431 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt/wt</sup>
###xml 454 458 442 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 468 471 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 481 485 465 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 533 540 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
Germ-free IL-10wt/wt;NF-kappaBEGFP and IL-10-/-;NF-kappaBEGFP mice were transferred to a specific-pathogen-free (SPF) environment and immediately placed on a diet containing 2% luteolin versus AIN-76 control chow (7/subgroup). After 4 weeks, mice were euthanized, and colonic EGFP-expression was imaged macroscopically and by confocal microscopy as described in figure 2 (A). Colonic histological sections from 4 weeks SPF-associated IL-10wt/wt;NF-kappaBEGFP and IL-10-/-;NF-kappaBEGFP mice were taken and scored as described in the Methods section (* p<0.05 versus AIN-76 control chow) (B).
###end p 131
###begin title 132
Luteolin blocks TNFalpha-induced NF-kappaB activity and suppresses TNFalpha-induced C-IAP1 and C-IAP2 mRNA accumulation in HT29 cells.
###end title 132
###begin p 133
###xml 596 601 <span type="species:ncbi:9606">human</span>
HT29 cells were infected with Ad5kappaB-LUC, and TNFalpha (5 ng/ml) was added in the presence or absence of various concentrations of luteolin. Luciferase activity after 16h was measured using an Lmax microplate reader and results were normalized for extract protein concentrations. Representative results of at least 3 independent experiments are shown (* p<0.01 versus TNFalpha alone) (A). HT29 cells were pretreated with luteolin (100 microM) for 45min, and then stimulated with TNFalpha (5 ng/ml) for 4 h. Total RNA (1 microg) was extracted, reverse-transcribed, and amplified using specific human C-IAP1, C-IAP2, X-IAP and beta-actin primers. Results are representative of three independent experiments (B).
###end p 133
###begin title 134
Luteolin-treatment sensitizes TNFalpha-exposed HT29 cells to DNA fragmentation and cytoplasmic accumulation of oligonucleosome-bound DNA.
###end title 134
###begin p 135
###xml 404 410 400 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Method</xref>
HT29 cells were pretreated with various concentration of luteolin alone or in combination with TNFalpha (20 ng/ml) for 24 h. Cells were lysed, DNA extracted and separated on a 1% agarose gel. Results are representative of three independent experiments (A). HT29 cells were treated as described above for 12 and 24 h. Cells were lysed and apoptosis measured using an ELISA-based assay as described in the Method section. Representative results of at least 3 independent experiments are shown (* p<0.01 versus TNFalpha alone) (B).
###end p 135
###begin title 136
Luteolin-treatment induces caspase 3, 8 and 9 activation in the presence of TNFalpha in HT29 cells.
###end title 136
###begin p 137
###xml 644 650 632 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Method</xref>
HT29 cells were treated with luteolin (100 microM) alone or in combination with TNFalpha (20 ng/ml) for 12 h. Cells were lysed, protein extracts (20 microg) were subjected to SDS-PAGE (13%) and caspase 3, 8 and 9 processing was evaluated by Western blot using specific antibodies for cleaved caspases 3, 8 and 9. Immunoreactive proteins were detected using the enhanced chemiluminescence (ECL) technique. Representative results of at least 3 independent experiments are shown (A). Cells were treated as described above for 12 and 24 h. Cells were lysed and caspase 3 activity was quantified using a fluorescence-based assay as described in the Method section. Representative results of at least 3 independent experiments are shown (* p<0.01 versus TNFalpha alone at 24 h) (B).
###end p 137
###begin title 138
Luteolin-treatment inhibits TNFalpha-induced COX-2 gene expression in HT29 cells.
###end title 138
###begin p 139
###xml 427 428 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 220 225 <span type="species:ncbi:9606">human</span>
HT29 cells were pretreated with luteolin (100 microM) for 45 min, and then stimulated with TNFalpha (5 ng/ml) for 4 h. Total RNA (1 microg) was extracted, reverse-transcribed, and COX-2 mRNA was amplified using specific human primers (A). Cells were treated as described above for 12 h and 24 h, and COX-2 protein accumulation was detected using Western blot analysis (B). Cells were treated as described above for 24 h and PGE2 production was measured from the cell culture supernatants using ELISA (* p<0.01 versus TNFalpha plus luteolin) (C). All data are representative of 3 independent experiments.
###end p 139
###begin title 140
###xml 127 130 127 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
Proposed model for the differential effect of luteolin in DSS-induced acute colitis and in spontaneous chronic colitis in IL-10-/--mice.
###end title 140
###begin p 141
###xml 38 42 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 575 578 567 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 588 592 576 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</sup>
###xml 43 58 <span type="species:ncbi:10090">transgenic mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
DSS-induced acute colitis in NF-kappaBEGFP transgenic mice correlates with enhanced EGFP expression (NF-kappaB activation) in the lamina propria due to the disruption of the epithelial monolayer and the uptake of luminal antigens by lamina propria mononuclear cells (A; middle panel). An impaired epithelial wound-healing response and increased apoptosis in luteolin-fed mice lead to enhanced EGFP expression in lamina propria mononuclear cells and exacerbate DSS-induced colitis (A; right panel). In the context of a primarily intact epithelial layer during colitis in IL-10-/-;NF-kappaBEGFP mice, luteolin decreases bacteria-induced EGFP expression in lamina propria mononuclear cells, which correlates with an attenuation of colitis (B; middle and right panel). Schematic representation of luteolin's impact on intestinal epithelial cells and lamina propria mononuclear cells: NF-kappaB activation in intestinal epithelial cells is likely protective (wound-healing response, anti-apoptotis), and its inhibition by luteolin consequently aggravates intestinal damage. As opposed, antigen- (e.g. bacteria-) induced NF-kappaB activation in lamina propria mononuclear cells leads to NF-kappaB dependent pro-inflammatory cytokine secretion, thus its inhibition by luteolin likely ameliorates intestinal inflammation (C).
###end p 141
###begin p 142
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 142
###begin p 143
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH ROI DK 47700 and American Institute of Cancer Research grants to C. Jobin; by the Crohn's and Colitis Foundation of America fellowship to T. Karrasch; by NIH P30 DK034987 to CGIBD and in part by NCI UNC GI SPORE grant P50 CA106991 to C. Jobin.
###end p 143

